scispace - formally typeset
M

Masa Bosnjak

Researcher at University of Ljubljana

Publications -  57
Citations -  724

Masa Bosnjak is an academic researcher from University of Ljubljana. The author has contributed to research in topics: Electrochemotherapy & Medicine. The author has an hindex of 12, co-authored 44 publications receiving 427 citations.

Papers
More filters
Journal ArticleDOI

Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study.

TL;DR: Electrochemotherapy of hepatocellular carcinoma proved to be a feasible and safe treatment in all 10 patients included in this study, and the results at medium observation period after treatment are encouraging.
Journal ArticleDOI

Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy

TL;DR: A new technological approach is described for electrochemotherapy of deep-seated head and neck tumors, coupling of the treatment planning with navigation system for accurate placement of the single long needle electrodes into and around the tumors, according to the treatment plan.
Journal ArticleDOI

Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.

TL;DR: The antitumor effectiveness of electrochemotherapy to intratumoral cisplatin administration is compared and it is concluded that the fraction of cells killed and the tumor cure rate are higher in immunogenic sarcoma tumor compared to moderately immunogenic carcinoma tumor.
Journal ArticleDOI

Cytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma Cells.

TL;DR: Results indicate that DNA electrotransfer may cause the upregulation of several intracellular DNA sensors in B16.F10 cells, inducing effects in vitro and potentially in vivo.
Journal ArticleDOI

Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results.

TL;DR: Effectiveness of electrochemotherapy was compared in patients with nonmelanoma skin cancer (NMSC) of the head and neck using standard and reduced doses of bleomycin.